Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

LFMD

LifeMD Inc

Jun 20 • 04:00PM ET

14.76

Dollar change -0.30
Percentage change -1.99	%

Healthcare • Health Information Services • USA • NASD

Peers: HIMS CVS TDOC AMWL DOCS LFST SEM AMED EHC CHE

| Held by: IWM VTI VXF IWO JSMD VTWO IWN IWC JSML VFMO

Index	RUT	P/E	-	EPS (ttm)	-0.33	Insider Own	20.45%	Shs Outstand	43.53M	Perf Week	16.22%
Market Cap	670.81M	Forward P/E	47.36	EPS next Y	0.31	Insider Trans	-4.42%	Shs Float	36.15M	Perf Month	38.72%
Income	-13.83M	PEG	-	EPS next Q	-0.01	Inst Own	36.40%	Short Float	9.71%	Perf Quarter	161.24%
Sales	234.01M	P/S	2.87	EPS this Y	103.23%	Inst Trans	2.99%	Short Ratio	2.05	Perf Half Y	153.61%
Book/sh	-0.05	P/B	-	EPS next Y	1718.04%	ROA	-15.89%	Short Interest	3.51M	Perf Year	75.71%
Cash/sh	0.76	P/C	19.51	EPS next 5Y	-	ROE	-	52W Range	3.99 - 15.29	Perf YTD	198.18%
Dividend Est.	-	P/FCF	48.12	EPS past 5Y	-10.98%	ROIC	-129.58%	52W High	-3.47%	Beta	2.43
Dividend TTM	-	Quick Ratio	0.77	Sales past 5Y	76.32%	Gross Margin	83.10%	52W Low	269.92%	ATR (14)	0.89
Dividend Ex-Date	-	Current Ratio	0.82	EPS Y/Y TTM	55.40%	Oper. Margin	-3.18%	RSI (14)	76.69	Volatility	5.79% 3.96%
Employees	336	Debt/Eq	-	Sales Y/Y TTM	43.07%	Profit Margin	-5.91%	Recom	1.25	Target Price	12.62
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	106.92%	Payout	-	Rel Volume	1.66	Prev Close	15.06
Sales Surprise	5.18%	EPS Surprise	118.90%	Sales Q/Q	48.83%	Earnings	May 06 AMC	Avg Volume	1.71M	Price	14.76
SMA20	17.33%	SMA50	56.33%	SMA200	130.28%	Trades		Volume	2,834,097	Change	-1.99%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-18-25	Reiterated	BTIG Research	Buy	$15 → $18
Dec-10-24	Initiated	Lake Street	Buy	$12
Dec-04-24	Initiated	Mizuho	Neutral	$7
Aug-23-24	Resumed	B. Riley Securities	Buy	$11
Jun-05-24	Initiated	KeyBanc Capital Markets	Overweight	$12
Nov-30-23	Initiated	Craig Hallum	Buy	$10
Jul-21-23	Initiated	Cantor Fitzgerald	Overweight	$7
Jul-03-23	Initiated	H.C. Wainwright	Buy	$9
Mar-10-22	Initiated	Colliers Securities	Buy	$14
Oct-04-21	Resumed	B. Riley Securities	Buy	$16

Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
Jun-10-25 04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
Jun-09-25 08:00AM	LifeMD to Participate in Two Investor Conferences During June (GlobeNewswire)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily) +5.24%
May-22-25 08:05AM	LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy (GlobeNewswire) +6.78%
04:05PM	Loading…
May-12-25 04:05PM	LifeMD to Participate in Three Investor Conferences During May (GlobeNewswire)
May-06-25 05:40PM	LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates (Zacks)
04:05PM	LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance (GlobeNewswire)
May-05-25 10:14AM	LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Apr-30-25 05:30AM	Why New Wegovy Deals Wont Restore Novo Nordisks Obesity Lead (The Wall Street Journal) -14.62%
Apr-29-25 03:19PM	Why Hims & Hers Health and LifeMD Are Skyrocketing Today (Motley Fool) +41.31%
10:30AM	Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback (Seeking Alpha)
08:05AM	LifeMD Announces Plans to Expand Affordable Access to Wegovy for Cash-Pay Patients (GlobeNewswire)
Apr-28-25 04:05PM	Medifast Announces First Quarter 2025 Financial Results (Business Wire)
04:05PM	LifeMD to Report First Quarter 2025 Financial Results on May 6 (GlobeNewswire)
08:00AM	Loading…
08:00AM	LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market (GlobeNewswire)
Apr-21-25 12:52PM	LifeMD, Inc. (LFMD): A Bull Case Theory (Insider Monkey)
Apr-17-25 08:00AM	LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs (GlobeNewswire) +8.05%
Apr-14-25 04:05PM	Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025 (Business Wire)
Apr-09-25 08:51AM	Agilon (AGL) Moves 26.1% Higher: Will This Strength Last? (Zacks) +7.88%
Apr-08-25 10:10AM	LifeMD Is Back To Life (Seeking Alpha)
Apr-01-25 04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
Mar-31-25 08:00AM	LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-28-25 09:21AM	Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect (Seeking Alpha)
Mar-25-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-11-25 03:02AM	LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions (GuruFocus.com) +30.56%
Mar-10-25 05:30PM	LifeMD Reports Fourth Quarter 2024 Results (GlobeNewswire) -8.57%
Mar-07-25 07:06AM	LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
08:00AM	Loading…
Mar-06-25 08:00AM	LifeMD Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound (GlobeNewswire)
Mar-05-25 08:00AM	LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Feb-25-25 08:05AM	LifeMD to Report Fourth Quarter 2024 Financial Results on March 10 (GlobeNewswire) -13.11%
Feb-24-25 08:05AM	LifeMD Announces Entry Into the Behavioral Health Market (GlobeNewswire)
Jan-28-25 08:00AM	LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) +6.80%
Jan-07-25 08:30AM	Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND For GLP-1 Users and Those Looking for Help to Keep Weight Off (Business Wire)
Dec-24-24 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Dec-05-24 08:30AM	Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential Even with Weight Loss Medications (Business Wire) -9.44%
08:00AM	LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution (GlobeNewswire)
Nov-12-24 08:00AM	LifeMD to Participate in Three Investor Conferences During November (GlobeNewswire)
Nov-07-24 04:05PM	LifeMD Reports Third Quarter 2024 Results (GlobeNewswire) +14.04%
Nov-06-24 08:00AM	LifeMD Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency (GlobeNewswire) +13.45%
07:45AM	Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result (GuruFocus.com)
Nov-04-24 04:05PM	Medifast Announces Third Quarter 2024 Financial Results (Business Wire)
Oct-24-24 08:26AM	LifeMD launches TestoRx, direct to consumer testosterone replacement therapy (TipRanks)
08:00AM	LifeMD to Report Third Quarter 2024 Financial Results on November 7 (GlobeNewswire)
Oct-23-24 08:00AM	LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering (GlobeNewswire)
Sep-24-24 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +10.94% -9.15%
Sep-19-24 08:00AM	LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options (GlobeNewswire)
Sep-11-24 02:01PM	Medifast (MED): A Bull Case Theory (Insider Monkey) +6.45%
Aug-26-24 04:05PM	LifeMD to Participate in Three Investor Conferences During September (GlobeNewswire) -9.74%
Aug-07-24 04:05PM	LifeMD Reports Second Quarter 2024 Results (GlobeNewswire) -7.17%
Jul-30-24 08:00AM	LifeMD to Report Second Quarter 2024 Financial Results on August 7 (GlobeNewswire)
Jul-25-24 08:00AM	LifeMD to Participate in Two Investor Conferences During August (GlobeNewswire)
Jul-16-24 07:05AM	3 Overlooked Telehealth Stocks Poised for a Comeback (InvestorPlace)
Jun-25-24 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
08:00AM	LifeMD Launches Commercial Health Insurance Acceptance for its Primary Care Services, Including Weight Management (GlobeNewswire)
Jun-10-24 08:00AM	LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit (GlobeNewswire)
May-29-24 08:00AM	LifeMD Set to Join the Russell 3000 Index (GlobeNewswire)
May-09-24 11:46AM	LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript (Insider Monkey) -24.57%
May-08-24 09:58PM	LFMD Stock Earnings: LifeMD Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance (GlobeNewswire)
May-02-24 08:00AM	LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition (GlobeNewswire) +7.30%
May-01-24 09:40AM	Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 08:00AM	LifeMD Appoints Dr. Calum MacRae to its Board of Directors (GlobeNewswire)
Apr-24-24 08:00AM	LifeMD to Report First Quarter 2024 Financial Results on May 8 (GlobeNewswire)
Apr-23-24 08:00AM	LifeMD to Participate in Upcoming Investor and Industry Conferences During May (GlobeNewswire) +8.90%
Mar-26-24 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-25-24 08:00AM	LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-11-24 05:30PM	LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.41%
04:05PM	LifeMD Reports Fourth Quarter 2023 Results (GlobeNewswire)
Feb-26-24 08:00AM	LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 (GlobeNewswire) +5.71%
Feb-15-24 08:00AM	LifeMD to Participate in Upcoming Investor Conferences and Webinar (GlobeNewswire)
Jan-31-24 08:00AM	LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Jan-18-24 08:00AM	LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference (GlobeNewswire)
Jan-08-24 08:00AM	LifeMD Provides 2024 Financial Guidance (GlobeNewswire) +6.97%
Jan-04-24 05:11PM	Why LifeMD's CEO isn't concerned about Eli Lilly's DTC site (Yahoo Finance Video) -32.05%
12:23PM	WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery (Bloomberg)
Dec-26-23 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Dec-13-23 05:22PM	Once an Ozempic Skeptic, This Diet-Company Giant Has Changed Its Mind (The Wall Street Journal) -6.42% +6.07%
06:01AM	Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight-Loss Drugs With New Deal (The Wall Street Journal)
06:00AM	LifeMD and Medifast Partner to Offer Transformative Weight Management Solution (GlobeNewswire)
Dec-07-23 08:00AM	LifeMD Executives to Participate in RWJBarnabas Health's Telehealth Symposium (GlobeNewswire)
Dec-05-23 10:25AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESSWIRE)
Nov-10-23 08:00AM	LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions (GlobeNewswire)
Nov-08-23 04:05PM	LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA (GlobeNewswire)
08:00AM	LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 (GlobeNewswire)
Oct-25-23 08:00AM	LifeMD to Report Third Quarter 2023 Financial Results on November 8 (GlobeNewswire)
Oct-09-23 09:55AM	Maxim Group LLC to Host the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, on Tuesday, October 10th & Wednesday, October 11th at 8:30 A.M. E.T. (GlobeNewswire)
Oct-03-23 06:00AM	Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy (GlobeNewswire)
Sep-27-23 08:00AM	LifeMD to Participate in Two Investor Conferences in October (GlobeNewswire)
Sep-26-23 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +12.42%
Sep-21-23 06:00AM	LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy (GlobeNewswire)
Aug-30-23 08:00AM	LifeMD to Participate in Two Investor Conferences in September (GlobeNewswire) +5.16%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-09-23 04:05PM	LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance (GlobeNewswire) +19.67%
Aug-02-23 08:00AM	LifeMD to Present at Sidotis Micro-Cap Virtual Conference (GlobeNewswire) -5.39%
Jul-26-23 08:00AM	LifeMD to Report Second Quarter 2023 Financial Results on August 9 (GlobeNewswire) +5.99%
Jul-23-23 05:24AM	TipRanks Perfect 10 List: Analysts Pound the Table on These Top-Rated Stocks (TipRanks)

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Benathen Marc David	Chief Financial Officer	Jun 16 '25	Sale	13.09	75,000	981,945	389,554	Jun 18 06:18 PM
Benathen Marc David	Chief Financial Officer	Jun 17 '25	Sale	14.01	50,000	700,495	339,554	Jun 18 06:18 PM
Yecies Eric Harold	Chief Legal Officer & GC	Jun 13 '25	Sale	12.25	15,000	183,750	16,100	Jun 17 06:12 PM
Galluppi Stefan	Chief Innovation Officer	Jun 13 '25	Sale	12.38	85,000	1,052,657	80,449	Jun 17 05:13 PM
Stefan Galluppi	Affiliate	Jun 13 '25	Proposed Sale	12.70	85,000	1,079,500		Jun 13 06:27 PM
Schreiber Justin	Chairman and CEO	Jun 02 '25	Sale	12.47	25,000	311,655	2,525,721	Jun 04 04:45 PM
Schreiber Justin	Chairman and CEO	May 01 '25	Sale	7.53	21,995	165,684	2,553,726	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	May 02 '25	Sale	7.50	3,005	22,539	2,550,721	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	Apr 29 '25	Sale	7.78	50,000	389,040	2,575,721	May 01 04:47 PM
Justin Schreiber	Chairman and CEO	Apr 29 '25	Proposed Sale	8.05	125,000	1,006,250		Apr 29 04:19 PM
FRIEDEMAN JESSICA	Chief Marketing Officer	Mar 14 '25	Sale	5.66	30,000	169,665	170,000	Mar 17 06:36 PM
Schreiber Justin	Chief Executive Officer	Feb 14 '25	Sale	7.55	50,000	377,620	2,653,715	Feb 21 05:34 PM
Schreiber Justin	Chief Executive Officer	Jan 02 '25	Sale	5.19	25,000	129,668	2,703,715	Jan 06 05:33 PM
Schreiber Justin	Chief Executive Officer	Dec 02 '24	Sale	6.52	25,000	162,925	2,728,715	Dec 04 05:07 PM
Justin Schreiber	CEO	Dec 02 '24	Proposed Sale	6.60	100,000	660,000		Dec 02 05:31 PM
Galluppi Stefan	Chief Innovation Officer	Sep 11 '24	Buy	4.93	3,000	14,790	45,449	Sep 12 02:10 PM

Dollar change +3.15
Percentage change 5.16	%

HIMS Hims & Hers Health Inc daily Stock Chart

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH VTI IWM VB VXF VBK IWO MDY IJK SCHA

Index	RUT	P/E	93.48	EPS (ttm)	0.69	Insider Own	10.43%	Shs Outstand	215.21M	Perf Week	12.37%
Market Cap	14.37B	Forward P/E	66.26	EPS next Y	0.97	Insider Trans	-8.73%	Shs Float	200.49M	Perf Month	4.92%
Income	164.40M	PEG	2.70	EPS next Q	0.15	Inst Own	70.32%	Short Float	30.37%	Perf Quarter	95.38%
Sales	1.78B	P/S	8.06	EPS this Y	27.49%	Inst Trans	-4.50%	Short Ratio	1.55	Perf Half Y	105.50%
Book/sh	2.46	P/B	26.14	EPS next Y	43.43%	ROA	24.54%	Short Interest	60.88M	Perf Year	165.92%
Cash/sh	1.44	P/C	44.55	EPS next 5Y	34.58%	ROE	36.79%	52W Range	13.47 - 72.98	Perf YTD	165.59%
Dividend Est.	-	P/FCF	61.10	EPS past 5Y	17.22%	ROIC	27.00%	52W High	-12.00%	Beta	2.10
Dividend TTM	-	Quick Ratio	1.32	Sales past 5Y	-	Gross Margin	68.19%	52W Low	376.76%	ATR (14)	4.60
Dividend Ex-Date	-	Current Ratio	1.59	EPS Y/Y TTM	6218.70%	Oper. Margin	6.48%	RSI (14)	66.71	Volatility	3.54% 4.13%
Employees	1637	Debt/Eq	0.12	Sales Y/Y TTM	85.99%	Profit Margin	9.21%	Recom	2.50	Target Price	47.83
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	313.81%	Payout	0.00%	Rel Volume	1.07	Prev Close	61.07
Sales Surprise	8.80%	EPS Surprise	65.43%	Sales Q/Q	110.67%	Earnings	May 05 AMC	Avg Volume	39.28M	Price	64.22
SMA20	14.19%	SMA50	36.05%	SMA200	92.72%	Trades		Volume	42,078,972	Change	5.16%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50

Show Previous Ratings

Today 12:49PM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily) +5.16%
Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
08:18AM	ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise? (Zacks)
08:17AM	Should You Add NVST Stock to Your Portfolio Right Now? (Zacks)
08:09AM	Loading…
08:09AM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily)
Jun-18-25 10:30AM	Where Will Hims & Hers Stock Be in 10 Years? (Motley Fool)
09:22AM	Reasons to Add PAHC Stock to Your Portfolio Right Now (Zacks)
08:30AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
08:28AM	Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? (Zacks)
04:20AM	Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) (Motley Fool)
Jun-17-25 08:39AM	DGX Stock Up on New Blood Test Development Deal With MD Anderson (Zacks)
Jun-16-25 04:00PM	These 2 Growth Stocks Are No-Brainer Buys Right Now (Motley Fool) +7.75%
11:19AM	GEHC Stock Declines Despite Expansion in Precision Care Capabilities (Zacks)
08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
08:25AM	Loading…
08:25AM	Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? (Zacks)
06:20AM	Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar? (Zacks)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
12:01AM	3 Reasons We Love Hims & Hers Health (HIMS) (StockStory)
Jun-11-25 09:32AM	Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to (Yahoo Finance)
08:35AM	Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? (Zacks)
Jun-10-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
08:06AM	Bruker Stock Set to Gain From Acquisition of Austria's biocrates (Zacks)
Jun-09-25 05:52PM	Markets Flat on No Economic or Trade News; Apple Flops at WWDC (Zacks)
12:20PM	Why Hims & Hers Health (HIMS) Might be Well Poised for a Surge (Zacks)
12:03PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
08:37AM	PEN Stock Rises Following the Launch of Ruby XL System (Zacks)
06:50PM	Loading…
Jun-08-25 06:50PM	Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? (Motley Fool)
Jun-07-25 06:52PM	Is Hims & Hers Health a Smart Buy Right Now? (Motley Fool)
04:15AM	This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space (Motley Fool)
Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
11:31AM	Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue? (Zacks)
08:52AM	Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? (Zacks)
08:29AM	Hims & Hers Stock: Buy the Dip or Wait It Out? (MarketBeat)
06:16AM	Hims & Hers Goes on a Buying Spree (Motley Fool)
Jun-04-25 12:33PM	HIMS Stock Falls Despite Latest Deal to Expand International Footprint (Zacks)
11:30AM	Why Is Hims & Hers Health (HIMS) Up 10.6% Since Last Earnings Report? (Zacks)
08:34AM	Should You Continue to Hold Labcorp Stock in Your Portfolio? (Zacks)
07:15AM	2 Incredible Growth Stocks to Buy Hand Over Fist (Motley Fool)
05:19AM	Zacks.com featured highlights EverQuote, Hims & Hers Health and Sprouts Farmers Market (Zacks)
Jun-03-25 04:11PM	Hims & Hers and Zava, Credo earnings, Kenvue: Trending Tickers (Yahoo Finance Video)
11:50AM	Top Stock Movers Now: Dollar General, Hims & Hers, Bumble, and More (Investopedia)
11:03AM	Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts (Barrons.com)
11:03AM	Hims & Hers Expands in Europe With Acquisition of ZAVA (Investopedia)
10:31AM	Hims & Hers, Joby Aviation, Pinterest: Trending Tickers (Yahoo Finance Video)
10:09AM	TMO Launches Next-Generation Mass Spectrometers: Stock to Gain? (Zacks)
10:05AM	The Bull Market is Back: 3 Stocks to Buy Now (HIMS, APP, META) (Zacks)
09:50AM	Why Hims & Hers Health, Inc. (HIMS) is a Top Momentum Stock for the Long-Term (Zacks)
08:53AM	IBD 50's Hims & Hers Erases Its 19% Acquisition-Tied Sprint (Investor's Business Daily)
08:53AM	IBD 50's Hims & Hers Health Shoots Higher On A Key Takeover In Europe (Investor's Business Daily)
08:08AM	QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances (Zacks)
07:41AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
07:15AM	Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland (Business Wire)
Jun-02-25 10:18AM	LH Stock Rises Following the Expansion of Precision Oncology Portfolio (Zacks)
09:00AM	Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know (Zacks)
08:12AM	Charles River Stock May Gain From Extended CHDI Research Deal on HD (Zacks)
06:20AM	Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) Be on Your Investing Radar? (Zacks)
06:20AM	Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar? (Zacks)
May-30-25 12:21PM	Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy? (Zacks) +7.94%
10:09AM	Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds (Zacks)
09:27AM	Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? (Zacks)
08:16AM	Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain? (Zacks)
May-29-25 10:30AM	Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly (Investor's Business Daily)
08:54AM	Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer (Zacks)
May-28-25 12:18PM	Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer (Zacks)
08:12AM	Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? (Zacks)
04:27AM	Why Hims & Hers Health Inc. (HIMS) Went Down On Tuesday (Insider Monkey)
May-27-25 11:37AM	3 Surprising Stocks That Have More Than Doubled in 2025 (Motley Fool)
May-26-25 08:38AM	TMO Stock Set to Gain From the Launch of New Narcotic Analyzers (Zacks)
06:20AM	Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now? (Zacks)
May-24-25 02:05PM	Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle (TipRanks)
07:00AM	MarketBeat Week in Review - 05/19 - 05/23 (MarketBeat)
May-23-25 10:47AM	RVTY Stock Falls Despite the Latest Launch of Automated Instrument (Zacks)
08:53AM	Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock (Zacks)
May-22-25 04:53PM	Why Hims & Hers Health (HIMS) Stock Is Falling Today (StockStory) -7.72%
03:39PM	Hims & Hers Introduces 6-Month Wegovy New Customer Offer (Business Wire)
01:57PM	Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off? (MarketBeat)
11:11AM	Snowflake stock gains, Nvidia & Navitas, Hims & Hers slips (Yahoo Finance Video)
09:33AM	Nvidia, Tesla lead over $250 billion in short-seller losses during massive market rally (Yahoo Finance)
May-21-25 01:08PM	MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio (Zacks) -5.24%
11:36AM	AST Business Growth & Strategic Acquisitions Support STERIS Stock (Zacks)
10:00AM	5 Single-Stock ETFs That Doubled in a Month (Zacks)
09:40AM	Are Medical Stocks Lagging DBV Technologies (DBVT) This Year? (Zacks)
May-20-25 11:31PM	Unpacking Q1 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks (StockStory)
12:53PM	Why Hims & Hers Health, Inc. (HIMS) Skyrocketed on Friday (Insider Monkey)
10:16AM	Hims & Hers Stock Chart Points to Strong Bullish Continuation (MarketBeat)
08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-19-25 09:13AM	ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues (Zacks)
07:47AM	Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs (Zacks)
07:02AM	Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now (Zacks)
May-16-25 01:26PM	Hims Stock Rockets On Novo Nordisk Partnership After FDA Weight-Loss Drug Ruling Crashes Shares (Investor's Business Daily) +10.36%
10:25AM	Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? (Zacks)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
06:19AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
May-15-25 08:55AM	Omnicell's New Perioperative Clinic Setting Products May Boost Stock (Zacks)
May-14-25 12:00PM	Hims & Hers Health, Inc. (HIMS) is a Great Momentum Stock: Should You Buy? (Zacks)
09:32AM	Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna (Yahoo Finance)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chi Michael	Chief Commercial Officer	Jun 17 '25	Sale	59.75	17,102	1,021,844	278,654	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Option Exercise	2.43	125,335	304,564	285,550	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.76	128,127	7,271,950	160,215	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 17 '25	Sale	59.22	65,110	3,855,542	95,105	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.51	47,534	2,686,300	237,660	Jun 17 08:07 PM
Boughton Soleil	Chief Legal Officer	Jun 16 '25	Sale	56.80	5,451	309,617	165,881	Jun 17 08:06 PM
Boughton Soleil	Chief Legal Officer	Jun 17 '25	Sale	59.75	2,572	153,677	163,309	Jun 17 08:06 PM
Becklund Irene	PAO	Jun 17 '25	Sale	59.75	8,485	506,979	712	Jun 17 08:06 PM
Chi Michael	Officer	Jun 17 '25	Proposed Sale	59.75	17,102	1,021,844		Jun 17 12:42 PM
Dudum Andrew	Officer	Jun 17 '25	Proposed Sale	59.22	65,110	3,855,544		Jun 17 12:13 PM
Becklund Irene	Officer	Jun 17 '25	Proposed Sale	59.75	8,485	506,979		Jun 17 11:19 AM
Boughton Soleil	Officer	Jun 17 '25	Proposed Sale	59.75	2,572	153,677		Jun 17 10:20 AM
Melissa Baird	Officer	Jun 16 '25	Proposed Sale	59.78	33,333	1,992,647		Jun 16 05:58 PM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.49	47,534	2,685,348		Jun 16 02:42 PM
Boughton Soleil	Officer	Jun 16 '25	Proposed Sale	56.80	5,451	309,617		Jun 16 11:53 AM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.43	128,127	7,230,643		Jun 16 11:24 AM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Option Exercise	6.82	5,400	36,828	261,980	Jun 11 08:09 PM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Sale	57.00	5,600	319,200	256,380	Jun 11 08:09 PM
Chi Michael	Officer	Jun 10 '25	Proposed Sale	57.00	5,400	307,800		Jun 10 12:12 PM
Chi Michael	Chief Commercial Officer	Jun 05 '25	Option Exercise	13.90	28,776	399,986	256,580	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Option Exercise	13.20	5,100	67,335	260,180	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Sale	56.00	5,100	285,600	256,580	Jun 09 04:58 PM
Chi Michael	Officer	Jun 06 '25	Proposed Sale	56.00	5,100	285,600		Jun 06 01:19 PM
Melissa Baird	Officer	Jun 04 '25	Proposed Sale	53.61	33,333	1,786,982		Jun 04 04:46 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Option Exercise	5.01	6,437	32,249	120,253	May 30 04:28 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Sale	52.98	11,581	613,537	39,153	May 30 04:28 PM
Boughton Soleil	Chief Legal Officer	May 27 '25	Sale	55.87	3,233	180,628	153,194	May 29 05:56 PM
Becklund Irene	PAO	May 22 '25	Sale	53.51	5,071	271,349	0	May 27 04:59 PM
Melissa Baird	Officer	May 27 '25	Proposed Sale	53.36	33,333	1,778,649		May 27 04:44 PM
Boughton Soleil	Officer	May 27 '25	Proposed Sale	55.87	3,233	180,628		May 27 11:12 AM
Becklund Irene	Officer	May 22 '25	Proposed Sale	53.51	5,071	271,349		May 22 09:45 AM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Option Exercise	10.97	6,437	70,646	125,397	May 19 06:35 PM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Sale	60.22	11,581	697,462	113,816	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Option Exercise	2.43	125,335	304,564	197,645	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.40	128,127	7,482,414	89,311	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.25	47,534	2,768,974	285,194	May 19 06:35 PM
Dudum Andrew	Officer	May 16 '25	Proposed Sale	58.36	175,661	10,251,390		May 16 11:08 AM
Baird Melissa	Chief Operating Officer	May 12 '25	Option Exercise	2.43	33,333	80,999	838,416	May 13 05:07 PM
Baird Melissa	Chief Operating Officer	May 12 '25	Sale	56.02	33,333	1,867,376	805,083	May 13 05:07 PM
Boughton Soleil	Chief Legal Officer	May 12 '25	Sale	56.00	3,235	181,160	156,427	May 13 05:07 PM
Melissa Baird	Officer	May 12 '25	Proposed Sale	55.21	33,333	1,840,315		May 12 05:10 PM
Boughton Soleil	Officer	May 12 '25	Proposed Sale	56.00	3,235	181,160		May 12 10:25 AM
Boughton Soleil	Chief Legal Officer	Apr 28 '25	Sale	30.19	3,236	97,695	159,662	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Option Exercise	2.43	50,000	121,500	142,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Option Exercise	2.43	41,667	101,251	133,770	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Sale	36.39	50,000	1,819,310	92,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Sale	30.19	41,667	1,257,760	92,103	Apr 30 06:01 PM
Dudum Andrew	Officer	Apr 29 '25	Proposed Sale	36.39	50,000	1,819,309		Apr 29 10:51 AM
Dudum Andrew	Officer	Apr 28 '25	Proposed Sale	30.19	41,667	1,257,753		Apr 28 12:51 PM
Boughton Soleil	Officer	Apr 28 '25	Proposed Sale	30.19	3,236	97,695		Apr 28 10:07 AM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Option Exercise	1.97	33,333	65,653	838,416	Apr 23 04:21 PM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Sale	25.78	33,333	859,256	805,083	Apr 23 04:21 PM
Becklund Irene	PAO	Apr 22 '25	Sale	26.49	2,936	77,775	5,071	Apr 23 04:21 PM
Becklund Irene	Officer	Apr 22 '25	Proposed Sale	26.49	2,936	77,775		Apr 22 09:46 AM
Melissa Baird	Officer	Apr 21 '25	Proposed Sale	25.84	33,333	861,325		Apr 21 04:37 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Option Exercise	2.43	33,668	81,813	128,563	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.23	47,534	1,342,094	332,728	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.04	36,460	1,022,453	92,103	Apr 18 03:40 PM
Boughton Soleil	Chief Legal Officer	Mar 03 '25	Sale	45.14	4,151	187,376	166,134	Apr 16 04:30 PM
Boughton Soleil	Chief Legal Officer	Apr 14 '25	Sale	28.72	3,236	92,938	162,898	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Option Exercise	6.43	6,437	41,377	130,541	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Sale	28.50	11,581	330,082	118,960	Apr 16 04:30 PM
Dudum Andrew	Officer	Apr 16 '25	Proposed Sale	28.15	83,994	2,364,547		Apr 16 10:44 AM
Boughton Soleil	Officer	Apr 14 '25	Proposed Sale	28.72	3,236	92,938		Apr 14 09:52 AM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Option Exercise	1.75	33,337	58,340	838,420	Apr 10 04:30 PM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Sale	27.32	33,337	910,687	805,083	Apr 10 04:30 PM
Melissa Baird	Officer	Apr 09 '25	Proposed Sale	29.49	33,337	983,108		Apr 09 04:42 PM
Baird Melissa	Chief Operating Officer	Apr 04 '25	Option Exercise	5.01	40,380	202,304	805,083	Apr 07 04:15 PM
Becklund Irene	PAO	Apr 03 '25	Sale	28.78	2,203	63,402	8,007	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Option Exercise	5.01	6,437	32,249	135,685	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Sale	29.26	11,581	338,833	124,104	Apr 04 04:52 PM
Becklund Irene	Officer	Apr 03 '25	Proposed Sale	28.78	2,203	63,402		Apr 03 10:29 AM
Baird Melissa	Chief Operating Officer	Mar 31 '25	Option Exercise	5.01	13,460	67,435	764,703	Apr 01 04:57 PM
Boughton Soleil	Chief Legal Officer	Mar 31 '25	Sale	27.77	3,236	89,864	170,285	Apr 01 04:57 PM
Boughton Soleil	Officer	Mar 31 '25	Proposed Sale	27.77	3,236	89,864		Mar 31 09:54 AM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Option Exercise	0.40	67,687	27,075	818,930	Mar 27 05:04 PM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Sale	34.84	67,687	2,358,145	751,243	Mar 27 05:04 PM
Melissa Baird	Officer	Mar 26 '25	Proposed Sale	33.36	67,687	2,258,038		Mar 26 04:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 21 '25	Sale	32.41	23,118	749,176	129,248	Mar 24 04:35 PM
Oluyemi Okupe	Officer	Mar 21 '25	Proposed Sale	34.75	69,442	2,413,110		Mar 21 05:00 PM
Carroll Patrick Harrison	Chief Medical Officer	Mar 18 '25	Sale	34.31	23,287	798,977	209,661	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Option Exercise	2.43	125,335	304,564	226,447	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.98	128,127	4,353,124	173,655	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 18 '25	Sale	33.85	78,760	2,666,199	94,895	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.64	47,534	1,599,170	380,262	Mar 18 06:35 PM
Boughton Soleil	Chief Legal Officer	Mar 18 '25	Sale	34.31	3,236	111,027	173,521	Mar 18 06:35 PM
Becklund Irene	PAO	Mar 18 '25	Sale	34.31	8,277	283,984	10,210	Mar 18 06:34 PM
Dudum Andrew	Officer	Mar 18 '25	Proposed Sale	33.85	78,760	2,666,200		Mar 18 12:24 PM
Boughton Soleil	Officer	Mar 18 '25	Proposed Sale	34.31	3,236	111,027		Mar 18 10:56 AM
Carroll Patrick Harrison	Officer	Mar 18 '25	Proposed Sale	34.31	23,287	798,977		Mar 18 10:52 AM
Becklund Irene	Officer	Mar 18 '25	Proposed Sale	34.31	8,277	283,984		Mar 18 10:24 AM
Dudum Andrew	Officer	Mar 17 '25	Proposed Sale	33.89	175,661	5,952,296		Mar 17 03:26 PM
Becklund Irene	PAO	Mar 11 '25	Sale	34.77	2,203	76,598	2,203	Mar 13 04:31 PM
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM
Boughton Soleil	Officer	Mar 03 '25	Proposed Sale	45.14	4,151	187,376		Mar 03 11:45 AM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Option Exercise	5.01	17,303	86,688	210,904	Feb 25 04:38 PM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Sale	48.14	17,303	832,966	193,601	Feb 25 04:38 PM

Dollar change -0.23
Percentage change -4.60	%

AIRS Airsculpt Technologies Inc daily Stock Chart

Peers: LGVN DERM HROW VRCA PMVP RCEL TVRD DBVT BKD CDTX

| Held by: IWM VTI VXF IWO SCHA VTWO ONEQ IWC VTWG RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.30	Insider Own	81.80%	Shs Outstand	58.66M	Perf Week	-9.14%
Market Cap	297.71M	Forward P/E	715.14	EPS next Y	0.01	Insider Trans	2.02%	Shs Float	11.36M	Perf Month	25.36%
Income	-17.13M	PEG	-	EPS next Q	0.01	Inst Own	22.10%	Short Float	61.14%	Perf Quarter	69.75%
Sales	172.10M	P/S	1.73	EPS this Y	-366.66%	Inst Trans	3.34%	Short Ratio	12.70	Perf Half Y	-20.23%
Book/sh	1.32	P/B	3.62	EPS next Y	112.50%	ROA	-8.44%	Short Interest	6.95M	Perf Year	19.55%
Cash/sh	0.09	P/C	53.64	EPS next 5Y	51.83%	ROE	-21.30%	52W Range	1.53 - 9.20	Perf YTD	-8.09%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-29.15%	ROIC	-10.11%	52W High	-48.15%	Beta	2.49
Dividend TTM	-	Quick Ratio	0.57	Sales past 5Y	34.33%	Gross Margin	52.58%	52W Low	211.76%	ATR (14)	0.45
Dividend Ex-Date	Aug 25, 2022	Current Ratio	0.57	EPS Y/Y TTM	-1199.26%	Oper. Margin	-4.02%	RSI (14)	58.33	Volatility	6.60% 5.21%
Employees	389	Debt/Eq	1.35	Sales Y/Y TTM	-12.96%	Profit Margin	-9.95%	Recom	2.50	Target Price	4.75
Option/Short	Yes / Yes	LT Debt/Eq	1.19	EPS Q/Q	-147.09%	Payout	-	Rel Volume	1.27	Prev Close	5.00
Sales Surprise	-0.08%	EPS Surprise	39.94%	Sales Q/Q	-17.32%	Earnings	May 02 BMO	Avg Volume	546.88K	Price	4.77
SMA20	1.09%	SMA50	40.94%	SMA200	2.27%	Trades		Volume	693,567	Change	-4.60%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	BTIG Research	Neutral
May-14-24	Downgrade	Leerink Partners	Outperform → Market Perform	$8.25 → $5
Nov-11-22	Downgrade	Piper Sandler	Overweight → Neutral	$4
Jun-16-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $8.50
Nov-23-21	Initiated	SVB Leerink	Outperform	$26
Nov-23-21	Initiated	Raymond James	Outperform	$18
Nov-23-21	Initiated	Piper Sandler	Overweight	$22
Nov-23-21	Initiated	Morgan Stanley	Overweight	$17

Jun-16-25 06:45AM	AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown (GlobeNewswire) +11.21%
Jun-11-25 04:05PM	AirSculpt Announces Closing of Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)
Jun-10-25 06:55AM	AirSculpt Announces Pricing of Offering of Common Stock (GlobeNewswire)
Jun-09-25 04:25PM	AirSculpt Announces Public Offering of Common Stock (GlobeNewswire)
May-27-25 12:00PM	AirSculpt Technologies, Inc. (AIRS) is a Great Momentum Stock: Should You Buy? (Zacks)
03:02AM	Loading…
May-03-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-02-25 11:02PM	Q1 2025 AirSculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) +33.63% -19.54%
01:12PM	AirSculpt Technologies, Inc. (AIRS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q1 Loss (Zacks)
06:00AM	AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance (GlobeNewswire)
May-01-25 09:32AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings (GuruFocus.com)
Apr-25-25 06:45AM	AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire) +7.69%
Apr-17-25 05:27AM	New Strong Sell Stocks for April 17th (Zacks) +6.92%
Apr-14-25 07:18AM	New Strong Sell Stocks for April 14th (Zacks)
Apr-02-25 06:07AM	New Strong Sell Stocks for April 2nd (Zacks)
12:16PM	Loading…
Apr-01-25 12:16PM	AirSculpt Technologies price target lowered to $2.50 from $6.50 at Leerink (TipRanks) -8.14%
Mar-26-25 05:33AM	New Strong Sell Stocks for March 26th (Zacks)
Mar-24-25 05:29AM	New Strong Sell Stocks for March 24th (Zacks)
Mar-15-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:48AM	Q4 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results (GlobeNewswire)
Mar-11-25 09:15AM	Unveiling AirSculpt Technologies (AIRS) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks) -11.45%
Mar-06-25 06:45AM	AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-13-25 06:45AM	AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025 (GlobeNewswire) -19.90%
Jan-07-25 06:45AM	AirSculpt Technologies Announces Participation in the ICR Conference 2025 (GlobeNewswire)
Dec-17-24 06:45AM	AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer (GlobeNewswire) +5.18%
Dec-10-24 10:42PM	Why Is AirSculpt Technologies Inc. (AIRS) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey) -5.67%
Dec-02-24 01:22PM	AirSculpt Technologies, Inc. Announces Opening of Its New White Plains, NY Center (PR Newswire)
Nov-09-24 02:04AM	AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
01:34AM	Loading…
01:34AM	Q3 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-24 09:30AM	AirSculpt Technologies (AIRS) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +20.72%
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results (GlobeNewswire)
Nov-07-24 07:09AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings (GuruFocus.com) -6.14%
Nov-05-24 11:17AM	AirSculpt Technologies (AIRS) Moves 14.2% Higher: Will This Strength Last? (Zacks)
Oct-24-24 06:30AM	AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results (GlobeNewswire) +5.26%
Oct-15-24 08:05AM	AirSculpt Technologies (AIRS) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Oct-01-24 12:48PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI (PR Newswire) -6.31%
Sep-24-24 01:30PM	AirSculpt Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand (PR Newswire) +7.34%
Sep-19-24 08:32AM	Do Options Traders Know Something About AirSculpt Technologies (AIRS) Stock We Don't? (Zacks) +6.77%
Aug-23-24 08:30AM	Implied Volatility Surging for AirSculpt Technologies (AIRS) Stock Options (Zacks)
Aug-19-24 12:00PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Columbus, OH (PR Newswire)
Aug-10-24 08:18AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies (AIRS) Q2 Earnings (Zacks)
07:25AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings and Revenues Miss Estimates (Zacks)
06:33AM	AirSculpt Technologies, Inc. (AIRS): The Best Cosmetic Surgery and Aesthetics Stocks To Buy? (Insider Monkey)
06:10AM	AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results (GlobeNewswire)
06:00AM	AirSculpt Technologies Announces Leadership Changes (GlobeNewswire)
Aug-07-24 09:15AM	Ahead of AirSculpt Technologies (AIRS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-17-24 06:00AM	3 Short-Squeeze Stocks to Buy Before July for 20% Returns (InvestorPlace)
May-31-24 09:36AM	Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't? (Zacks)
May-24-24 09:55AM	Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher (Zacks)
09:35AM	Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround (Zacks)
May-13-24 03:06AM	AirSculpt Technologies Inc (AIRS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-11-24 10:19AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:32PM	AirSculpt Technologies Inc (AIRS) Exceeds First Quarter Revenue Estimates with Strong Performance (GuruFocus.com) -12.06%
01:48PM	AirSculpt Technologies Shares Down After Q1 Adjusted Earnings Fall (MT Newswires)
10:53AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics (Zacks)
07:15AM	AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports for First Quarter Earnings (GlobeNewswire)
May-08-24 09:15AM	Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-30-24 07:00AM	AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-29-24 08:30AM	AirSculpt Relocates and Expands to New Location to Meet Market Demand (PR Newswire)
Mar-19-24 08:30AM	AirSculpt Announces Kristen Doute, Star of Bravo's The Valley As Latest AirSculpt Client (PR Newswire)
Mar-18-24 07:00AM	Bear of the Day: AirSculpt (AIRS) (Zacks)
Mar-12-24 03:59PM	Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics (InvestorPlace)
Mar-10-24 10:18AM	10 Botox Alternatives for Smoothing Wrinkles and Anti-Aging Treatment (Insider Monkey)
Mar-07-24 07:00AM	AirSculpt Technologies Announces Participation at BofA Securities Consumer and Retail Conference (GlobeNewswire)
Mar-04-24 08:30AM	AirSculpt Technologies, Inc. Expands Its Scottsdale Location (PR Newswire) -5.10%
Feb-29-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Chemours, Methanex, and AirSculpt and Encourages Investors to Contact the Firm (GlobeNewswire)
Feb-28-24 08:52AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 09:53PM	Q4 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Q4 Earnings and Revenues Miss Estimates (Zacks)
06:36AM	AirSculpt Technologies Inc (AIRS) Reports Strong Revenue and EBITDA Growth in Q4 and Full Year 2023 (GuruFocus.com)
06:00AM	AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023 (GlobeNewswire)
Feb-26-24 07:28PM	AirSculpt Technologies, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire) +7.86%
09:16AM	What Analyst Projections for Key Metrics Reveal About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
Feb-23-24 09:15AM	Airsculpt shares slide after Fuzzy Panda takes short position (Reuters) -5.65%
Jan-31-24 07:00AM	AirSculpt Technologies Announces Fourth Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-25-24 12:00PM	What Makes AirSculpt Technologies, Inc. (AIRS) a New Strong Buy Stock (Zacks)
Jan-01-24 09:40AM	Is AirSculpt Technologies (AIRS) Outperforming Other Business Services Stocks This Year? (Zacks)
Dec-19-23 08:34AM	Are Options Traders Betting on a Big Move in AirSculpt (AIRS) Stock? (Zacks)
Nov-11-23 08:42AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 09:54PM	Q3 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) -10.04%
Nov-09-23 07:00PM	AirSculpt Technologies, Inc. (AIRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -9.06%
04:01PM	AirSculpt Technologies Announces Third Quarter 2023 Results and Reaffirms 2023 Guidance (GlobeNewswire)
Nov-08-23 12:28PM	AirSculpt (AIRS) to Report Q3 Earnings: What's in the Cards? (Zacks)
Nov-03-23 10:00AM	AirSculpt Technologies, Inc. (AIRS) Earnings Expected to Grow: Should You Buy? (Zacks) +9.36%
Nov-01-23 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
Oct-27-23 07:00AM	AirSculpt Technologies Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-17-23 09:30AM	AirSculpt Technologies, Inc. Announces Partnership with Singer and TV Personality, Joey Fatone to Transform his Body with AirSculpt (GlobeNewswire)
Oct-16-23 09:40AM	Is AirSculpt Technologies (AIRS) Stock Outpacing Its Business Services Peers This Year? (Zacks) +5.52%
Oct-05-23 07:00AM	AirSculpt Technologies Announces Strong Preliminary Third Quarter 2023 Revenue Results and Updates 2023 Revenue and Adjusted EBITDA Guidance (GlobeNewswire)
Sep-25-23 09:40AM	Is AirSculpt Technologies (AIRS) Outperforming Other Business Services Stocks This Year? (Zacks)

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feinstein Adam T	Director	Jun 09 '25	Buy	4.00	1,000,000	4,000,000	14,038,819	Jun 11 05:06 PM
Rollins Aaron	Executive Chairman	May 19 '25	Buy	3.60	2,118	7,629	15,146,039	May 20 04:11 PM
Jashnani Yogesh	Chief Executive Officer	May 07 '25	Buy	2.65	7,000	18,532	464,879	May 07 05:56 PM
Rollins Aaron	Executive Chairman	Nov 15 '24	Sale	6.54	49,019	320,815	14,986,689	Nov 15 09:44 PM
Rollins Aaron	Executive Chairman	Nov 14 '24	Sale	7.17	44,756	320,677	15,035,708	Nov 15 09:44 PM
Rollins Aaron	Executive Chairman	Nov 13 '24	Sale	7.53	15,438	116,231	15,080,464	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 15 '24	Sale	6.54	24,510	160,411	582,052	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 14 '24	Sale	7.17	22,378	160,338	606,562	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 13 '24	Sale	7.53	7,719	58,116	628,940	Nov 15 09:44 PM
Dennis Dean	Interim CEO and CFO	Nov 15 '24	Proposed Sale	6.51	2,561	16,672		Nov 15 09:33 PM
Dennis Dean	Interim CEO and CFO	Nov 12 '24	Proposed Sale	7.19	52,046	374,217		Nov 13 02:03 PM
Todd Magazine	Former Officer and Director	Sep 16 '24	Proposed Sale	4.26	76,693	326,932		Oct 25 07:22 PM

Dollar change +0.01
Percentage change 0.42	%

TOI Oncology Institute Inc daily Stock Chart

Peers: AMGN BMY PFE MRK LLY AZN GILD REGN VRTX BIIB

| Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-0.70	Insider Own	55.44%	Shs Outstand	88.93M	Perf Week	-9.81%
Market Cap	219.67M	Forward P/E	-	EPS next Y	-0.09	Insider Trans	-5.88%	Shs Float	40.96M	Perf Month	-14.03%
Income	-52.80M	PEG	-	EPS next Q	-0.09	Inst Own	14.73%	Short Float	3.81%	Perf Quarter	148.96%
Sales	403.15M	P/S	0.54	EPS this Y	46.48%	Inst Trans	9.24%	Short Ratio	1.01	Perf Half Y	1114.43%
Book/sh	0.06	P/B	41.93	EPS next Y	76.32%	ROA	-28.66%	Short Interest	1.56M	Perf Year	427.36%
Cash/sh	0.43	P/C	5.53	EPS next 5Y	-	ROE	-227.77%	52W Range	0.13 - 3.50	Perf YTD	673.46%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-488.57%	ROIC	-52.51%	52W High	-31.71%	Beta	0.16
Dividend TTM	-	Quick Ratio	1.59	Sales past 5Y	-	Gross Margin	13.07%	52W Low	1807.42%	ATR (14)	0.28
Dividend Ex-Date	-	Current Ratio	1.79	EPS Y/Y TTM	13.86%	Oper. Margin	-12.91%	RSI (14)	41.01	Volatility	2.54% 5.45%
Employees	825	Debt/Eq	20.18	Sales Y/Y TTM	17.64%	Profit Margin	-13.10%	Recom	1.00	Target Price	7.00
Option/Short	No / Yes	LT Debt/Eq	18.83	EPS Q/Q	4.88%	Payout	-	Rel Volume	1.54	Prev Close	2.38
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	10.29%	Earnings	May 14 AMC	Avg Volume	1.54M	Price	2.39
SMA20	-15.47%	SMA50	-10.41%	SMA200	126.71%	Trades		Volume	2,369,239	Change	0.42%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-25	Initiated	BTIG Research	Buy	$7
Feb-26-24	Resumed	Jefferies	Buy	$2.50
Sep-14-22	Initiated	Guggenheim	Buy	$7
Aug-15-22	Initiated	Jefferies	Buy	$10

Jun-03-25 08:00AM	The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 04:06PM	The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire) -10.57% +28.27%
04:05PM	The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer (GlobeNewswire)
May-13-25 07:08PM	Topicus.com Inc. Announces Election of Members of the Board of Directors (GlobeNewswire)
04:05PM	The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference (GlobeNewswire)
08:00AM	Loading…
May-08-25 08:00AM	The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates (GlobeNewswire) +6.18%
May-07-25 05:03PM	Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 (GlobeNewswire) +5.36%
May-01-25 05:48PM	Topicus.com Inc. Defers Release Date for First Quarter Results (GlobeNewswire) +12.50%
Apr-30-25 06:04AM	Why The Oncology Institute, Inc. (TOI) is Surging in 2025 (Insider Monkey)
Apr-26-25 11:00AM	Microsoft, Apple Set To Report Earnings As Markets Watch Out For Core PCE Price Index (Seeking Alpha)
Apr-23-25 08:00AM	The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire) +6.27%
Apr-22-25 04:05PM	The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials (GlobeNewswire) +13.39%
Apr-01-25 10:04AM	The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 (Insider Monkey) +10.53%
Mar-31-25 08:00AM	TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 (GlobeNewswire)
Mar-26-25 03:02AM	The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
06:28PM	Loading…
Mar-25-25 06:28PM	The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript (SeekingAlpha)
Mar-24-25 09:05AM	Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q4 2024 Result (GuruFocus.com) +24.47%
06:01AM	The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 (GlobeNewswire)
06:00AM	The Oncology Institute Announces $16.5 million Private Placement (GlobeNewswire)
Mar-04-25 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-26-25 08:00AM	The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown (GlobeNewswire) +19.66%
Dec-18-24 04:05PM	Florida Blue enhances cancer care for thousands of members (GlobeNewswire) +11.12%
Nov-13-24 04:05PM	The Oncology Institute Reports Third Quarter 2024 Financial Results (GlobeNewswire) -9.03% -10.84%
Nov-11-24 08:00AM	The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California (GlobeNewswire)
Nov-04-24 07:09PM	The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire) -6.64%
Oct-23-24 08:00AM	The Oncology Institute Joins Lantern's Cancer Care Network of Excellence (GlobeNewswire)
Oct-14-24 08:00AM	The American Journal of Managed Care and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care (GlobeNewswire)
Sep-30-24 08:00AM	The Oncology Institute of Hope & Innovation Launches Oregon Market (GlobeNewswire) +5.59%
Sep-23-24 08:00AM	The Oncology Institute Announces CFO Transition (GlobeNewswire)
Aug-13-24 04:05PM	The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance (GlobeNewswire) +13.40% -18.18%
08:00AM	Loading…
Jul-23-24 08:00AM	The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
May-29-24 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-22-24 08:00AM	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference (GlobeNewswire)
May-15-24 03:14AM	The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -24.00%
May-14-24 06:05PM	The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance (GlobeNewswire)
May-07-24 04:05PM	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit (GlobeNewswire) -6.08%
Apr-23-24 08:00AM	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-08-24 08:00AM	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute (GlobeNewswire) +6.00%
Apr-04-24 08:00AM	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California (GlobeNewswire)
Apr-01-24 01:35PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 08:52PM	TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +8.88% -14.13%
05:34PM	The Oncology Institute Inc (TOI) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 (GlobeNewswire)
Mar-21-24 09:35AM	Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround (Zacks)
Mar-14-24 08:09AM	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership (GlobeNewswire) +5.62%
Mar-06-24 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-27-24 04:05PM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-20-24 08:00AM	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model (GlobeNewswire)
Jan-25-24 08:00AM	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio (GlobeNewswire)
Dec-04-23 08:00AM	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California (GlobeNewswire)
Nov-16-23 05:04AM	Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI) (GuruFocus.com) -7.21%
Nov-11-23 12:43PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:50PM	The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens (GuruFocus.com) +5.75% +27.72%
04:05PM	The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Oct-18-23 08:03AM	The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-11-23 04:05PM	The Oncology Institute Names Jeremy Castle as Chief Operations Officer (GlobeNewswire)
Sep-26-23 04:05PM	The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit (GlobeNewswire)
Sep-18-23 08:00AM	The Oncology Institute Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Aug-09-23 08:10AM	Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology (GlobeNewswire)
Aug-08-23 04:40PM	The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Aug-02-23 06:16AM	Oncology Institute (NASDAQ:TOI) shareholders have endured a 90% loss from investing in the stock three years ago (Simply Wall St.) -5.71%
Jul-31-23 08:00AM	The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations (GlobeNewswire)
Jul-18-23 08:00AM	The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jun-12-23 06:00AM	The Oncology Institute Announces Leadership Transition (GlobeNewswire) -9.02%
Jun-09-23 08:00AM	The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research (GlobeNewswire) -5.31%
Jun-07-23 08:00AM	The Oncology Institute to Open Project Southland (GlobeNewswire) +17.07%
May-31-23 08:01AM	The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting (GlobeNewswire)
08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-10-23 04:05PM	The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
May-04-23 11:47AM	The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education (PR Newswire)
May-02-23 08:00AM	TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer (GlobeNewswire) -6.51%
Apr-19-23 08:00AM	The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Mar-16-23 08:08PM	CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -12.41% -17.07%
Mar-09-23 04:20PM	The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -11.35% -19.60%
Feb-28-23 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-16-23 08:00AM	The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Dec-19-22 08:00AM	The Oncology Institute Expands Into Chino, CA (GlobeNewswire)
Dec-15-22 08:00AM	The Oncology Institute Rebrands Clinical Trials Division (GlobeNewswire) -7.26%
Nov-22-22 08:00AM	The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa (GlobeNewswire) +5.70%
Nov-09-22 04:05PM	The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance (GlobeNewswire) -5.16%
Nov-01-22 08:00AM	The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference (GlobeNewswire) -8.59%
Oct-19-22 08:00AM	The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-17-22 04:05PM	The Oncology Institute Executives to Speak at Key Industry Conferences in Q4 (GlobeNewswire) +6.08%
Oct-11-22 08:00AM	The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials (GlobeNewswire) +5.37%
Oct-06-22 08:00AM	The Oncology Institute Expands into South Florida (GlobeNewswire)
Sep-29-22 08:00AM	The Oncology Institute Enrolls Nations First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib (GlobeNewswire)
Sep-22-22 04:05PM	The Oncology Institute Appoints Two New Board Members (GlobeNewswire)
Sep-15-22 08:00AM	The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium (GlobeNewswire) -7.62%
Sep-12-22 08:00AM	The Oncology Institute Becomes Certified as a Patient Safety Organization (GlobeNewswire)
Aug-22-22 08:00AM	The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms (GlobeNewswire)
Aug-16-22 08:00AM	The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day (GlobeNewswire) +9.21%
Aug-09-22 04:06PM	The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance (GlobeNewswire) +9.95%
04:05PM	The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets (GlobeNewswire)
Jul-26-22 08:00AM	The Oncology Institute Continues its Nevada Expansion (GlobeNewswire)
Jul-19-22 08:00AM	The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-07-22 04:05PM	The Oncology Institute Continues Southern California Expansion (GlobeNewswire) -5.51%
Jun-27-22 08:00AM	The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals (GlobeNewswire) -6.55%
Jun-21-22 08:00AM	The Oncology Institute to Participate at the Cowen Virtual FutureHealth Conference (GlobeNewswire)
Jun-07-22 04:05PM	The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes (GlobeNewswire) -8.96%

The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	673,676	2,054,712	13,950,557	Jun 09 04:15 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	76,324	232,788	1,272,724	Jun 09 04:15 PM
Hively Brad	Director	Jun 03 '25	Option Exercise	0.90	1,867,605	1,682,524	2,579,638	Jun 05 06:51 PM
Hively Brad	Director	Jun 03 '25	Sale	2.87	1,976,137	5,672,106	603,501	Jun 05 06:51 PM
TOI M, LLC	10% Owner	Jun 05 '25	Proposed Sale	3.20	127,207	407,062		Jun 05 06:17 PM
M33 Growth I L.P.	10% Owner	Jun 05 '25	Proposed Sale	3.20	1,122,793	3,592,938		Jun 05 06:13 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	39,600	113,652		Jun 03 05:08 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	1,936,537	5,557,861		Jun 03 04:27 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	1,796,468	4,873,638	14,624,233	May 22 07:38 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	203,532	552,162	1,349,048	May 22 07:38 PM
TOI M, LLC	10% Owner	May 20 '25	Proposed Sale	3.06	203,532	622,808		May 20 06:25 PM
M33 Growth I L.P.	10% Owner	May 20 '25	Proposed Sale	3.06	1,796,468	5,497,192		May 20 06:19 PM
Virnich Daniel	Chief Executive Officer	Mar 26 '25	Buy	1.04	22,640	23,584	724,363	Mar 28 05:50 PM
Podnos Yale	Chief Medical Officer	Mar 26 '25	Buy	1.04	9,056	9,434	79,049	Mar 28 05:48 PM
Pacala Mark L	Director	Mar 26 '25	Buy	1.04	90,562	94,338	224,971	Mar 28 05:41 PM
Johnson Karen Marie	Director	Mar 26 '25	Buy	1.04	36,224	37,735	203,409	Mar 28 05:36 PM
Hively Brad	Director	Mar 26 '25	Buy	1.04	9,056	9,434	675,809	Mar 28 05:34 PM
Castle Jeremy	Chief Operating Officer	Mar 26 '25	Buy	1.04	9,056	9,434	90,386	Mar 28 05:33 PM
Carter Robert Ross	Chief Financial Officer	Mar 26 '25	Buy	1.04	9,056	9,434	39,407	Mar 28 05:27 PM
BARASCH RICHARD A	Director	Mar 26 '25	Buy	1.04	1,358,448	1,415,095	1,775,641	Mar 28 05:25 PM
Hively Brad	Director	Nov 26 '24	Buy	0.17	250,000	42,500	616,753	Dec 02 04:04 PM
Hively Brad	Director	Dec 02 '24	Buy	0.15	50,000	7,500	666,753	Dec 02 04:04 PM

TDOC Teladoc Health Inc daily Stock Chart

Peers: AMWL DOCS TVRD HIMS GDRX CLOV OSCR ACHC MD RMTI

| Held by: VTI IWM VB VXF VBK IWN DFAT VTWO FNDA SCHA

Index	RUT	P/E	-	EPS (ttm)	-5.93	Insider Own	1.12%	Shs Outstand	175.34M	Perf Week	-3.77%
Market Cap	1.21B	Forward P/E	-	EPS next Y	-0.90	Insider Trans	-5.72%	Shs Float	173.47M	Perf Month	-5.99%
Income	-1012.37M	PEG	-	EPS next Q	-0.26	Inst Own	73.74%	Short Float	13.29%	Perf Quarter	-15.54%
Sales	2.55B	P/S	0.47	EPS this Y	80.40%	Inst Trans	3.82%	Short Ratio	4.46	Perf Half Y	-35.39%
Book/sh	8.14	P/B	0.85	EPS next Y	21.94%	ROA	-26.07%	Short Interest	23.05M	Perf Year	-31.75%
Cash/sh	6.80	P/C	1.01	EPS next 5Y	45.59%	ROE	-54.49%	52W Range	6.35 - 15.21	Perf YTD	-24.09%
Dividend Est.	-	P/FCF	4.20	EPS past 5Y	-33.66%	ROIC	-41.27%	52W High	-54.64%	Beta	1.78
Dividend TTM	-	Quick Ratio	1.61	Sales past 5Y	35.95%	Gross Margin	56.24%	52W Low	8.66%	ATR (14)	0.30
Dividend Ex-Date	-	Current Ratio	1.65	EPS Y/Y TTM	-322.03%	Oper. Margin	-7.31%	RSI (14)	43.87	Volatility	1.77% 2.34%
Employees	5500	Debt/Eq	1.11	Sales Y/Y TTM	-2.54%	Profit Margin	-39.66%	Recom	2.60	Target Price	8.71
Option/Short	Yes / Yes	LT Debt/Eq	0.72	EPS Q/Q	-9.40%	Payout	-	Rel Volume	1.10	Prev Close	7.01
Sales Surprise	1.64%	EPS Surprise	-54.74%	Sales Q/Q	-2.59%	Earnings	Apr 30 AMC	Avg Volume	5.16M	Price	6.90
SMA20	-2.25%	SMA50	-3.09%	SMA200	-22.88%	Trades		Volume	5,676,905	Change	-1.57%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-28-22	Downgrade	Goldman	Buy → Neutral	$55 → $36
Jul-06-22	Reiterated	BofA Securities	Neutral	$36 → $42
May-05-22	Downgrade	Argus	Buy → Hold
Apr-28-22	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
Jun-16-25 06:15PM	Teladoc (TDOC) Rises Higher Than Market: Key Facts (Zacks)
Jun-13-25 06:30AM	What are the top holdings of Cathie Wood's ARK Innovation ETF? (Yahoo Finance Video)
Jun-12-25 05:45AM	M&A to play important role at Teladoc: CEO (Healthcare Dive)
Jun-09-25 06:15PM	Teladoc (TDOC) Outperforms Broader Market: What You Need to Know (Zacks)
12:20PM	Loading…
Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
11:44AM	Doximity Declines 4.4% in a Month: How to Play the Stock Now? (Zacks)
08:00AM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Jun-04-25 08:41AM	Doximity Rides on Telehealth Demand: Will This Drive Sales Further? (Zacks)
Jun-03-25 04:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
Jun-02-25 12:40AM	3 of Wall Street's Favorite Stocks Walking a Fine Line (StockStory)
May-30-25 11:31AM	Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report? (Zacks)
May-23-25 12:33AM	1 Russell 2000 Stock for Long-Term Investors and 2 to Be Wary Of (StockStory)
May-21-25 04:19PM	Hinge Health, MNTN IPOs Test Strength of US Listing Rebound (Bloomberg) -5.04%
May-20-25 07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
12:38AM	Loading…
May-19-25 12:38AM	3 Value Stocks in Hot Water (StockStory)
May-16-25 10:25AM	Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? (Zacks)
05:30AM	1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid (Motley Fool)
May-08-25 11:39AM	TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit (Zacks)
10:12AM	Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now (Insider Monkey)
May-06-25 09:45AM	Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare (PR Newswire) -5.17%
May-03-25 10:00AM	Teladoc Health: No Real Rescue In Sight (Seeking Alpha)
May-02-25 09:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
May-01-25 09:05AM	Q1 2025 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
05:59AM	Teladoc acquires mental health firm UpLift as BetterHelp earnings slide (Healthcare Dive)
03:17AM	Teladoc Health Inc (TDOC) Q1 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Apr-30-25 09:42PM	Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:00PM	Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:24PM	Teladoc: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Teladoc Health Reports First Quarter 2025 Results (GlobeNewswire)
04:01PM	Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits (GlobeNewswire)
12:43PM	Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now? (Zacks)
Apr-29-25 03:08AM	Teladoc (TDOC) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-28-25 09:16AM	Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
05:03AM	Online Marketplace Stocks Q4 Teardown: CarGurus (NASDAQ:CARG) Vs The Rest (StockStory)
Apr-25-25 06:15PM	Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why (Zacks)
Apr-21-25 05:29PM	Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? (Insider Monkey) +5.99%
Apr-16-25 06:00PM	Teladoc Health to Announce First Quarter 2025 Financial Results (GlobeNewswire)
11:48AM	Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (Seeking Alpha)
08:43AM	Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it (Zacks)
Apr-12-25 02:05PM	2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction (Motley Fool)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)
Apr-08-25 06:15PM	Teladoc (TDOC) Stock Moves -0.97%: What You Should Know (Zacks) +10.06%
06:00AM	Teladoc Health Introduces Next Generation Cardiometabolic Health Program (GlobeNewswire)
Apr-02-25 06:15PM	Teladoc (TDOC) Gains But Lags Market: What You Should Know (Zacks)
Apr-01-25 04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
Mar-30-25 09:30AM	Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? (Motley Fool)
Mar-28-25 11:30AM	Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report? (Zacks) -5.49%
Mar-26-25 06:15PM	Teladoc (TDOC) Flat As Market Sinks: What You Should Know (Zacks)
09:15AM	Teladoc's Meltdown May Not Be Over Yet - Minimal Growth Opportunities (SeekingAlpha)
05:14AM	Teladoc (TDOC): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-25-25 08:45AM	AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs (GlobeNewswire)
Mar-19-25 06:15PM	Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider (Zacks)
Mar-18-25 01:49PM	Teladoc Health (TDOC): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey) -5.41%
05:05AM	Spotting Winners: Teladoc (NYSE:TDOC) And Online Marketplace Stocks In Q4 (StockStory)
Mar-17-25 04:13AM	Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy? (Motley Fool)
Mar-13-25 09:02AM	Carrum Health Selected by Teladoc Health as Centers of Excellence Partner (PR Newswire)
05:04AM	A Look Back at Online Marketplace Stocks Q4 Earnings: Shutterstock (NYSE:SSTK) Vs The Rest Of The Pack (StockStory)
Mar-12-25 09:00AM	Cylinder joins Teladoc Healths Connected Care Program to expand access to virtual digestive care (GlobeNewswire)
Mar-11-25 06:15PM	Teladoc (TDOC) Advances While Market Declines: Some Information for Investors (Zacks)
08:00AM	Teladoc Health Expands Connected Care Partnerships (GlobeNewswire)
05:04AM	Q4 Rundown: The RealReal (NASDAQ:REAL) Vs Other Online Marketplace Stocks (StockStory)
05:01AM	Q4 Online Marketplace Earnings: MercadoLibre (NASDAQ:MELI) Earns Top Marks (StockStory)
Mar-10-25 05:05AM	Q4 Earnings Highs And Lows: EverQuote (NASDAQ:EVER) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Mar-07-25 08:02AM	3 Small-Cap Stocks in the Doghouse (StockStory)
Mar-06-25 03:52PM	Teladoc stock jumps on GLP-1 deal with Eli Lilly (Yahoo Finance Video)
02:27PM	Teladoc partners with Eli Lilly, Burlington stock rises: Market Minute (Yahoo Finance Video)
11:29AM	Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss (Benzinga)
08:31AM	Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care (GlobeNewswire)
Mar-05-25 06:00PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
Mar-04-25 08:00AM	Teladoc Health Connects Digital & Community Providers to Deliver Next Generation of Virtually Integrated Care (GlobeNewswire)
Mar-03-25 06:15PM	Teladoc (TDOC) Stock Moves -1.36%: What You Should Know (Zacks)
Feb-28-25 10:27AM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
Feb-27-25 04:29PM	These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com) -13.56%
03:06PM	Why Teladoc (TDOC) Stock Is Trading Lower Today (StockStory)
02:57PM	Why Teladoc Stock Is Plummeting Today (Motley Fool)
12:59PM	Teladoc Health, Virgin Galactic: Trending Tickers (Yahoo Finance Video)
11:55AM	These Stocks Are Moving the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com)
07:21AM	Q4 2024 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
06:44AM	Teladoc Health Shares Plunge 15% After-Hours as Q4 Loss Widens, Revenue Declines (GuruFocus.com)
06:02AM	Teladoc posts $1B loss in 2024 as BetterHelp lags (Healthcare Dive)
02:21AM	Teladoc Health Inc (TDOC) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Feb-26-25 11:00PM	Teladoc Health (TDOC) Q4 2024 Earnings Call Transcript (Motley Fool)
06:30PM	Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings (Zacks)
06:15PM	Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:12PM	Teladoc: Q4 Earnings Snapshot (Associated Press Finance)
04:29PM	Teladocs (NYSE:TDOC) Q4 Earnings Results: Revenue In Line With Expectations But Stock Drops 11.7% (StockStory)
04:05PM	Teladoc Health Reports Full Year and Fourth Quarter 2024 Results (GlobeNewswire)
Feb-25-25 08:08AM	Teladoc (TDOC) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-24-25 04:30PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Feb-21-25 09:15AM	What Analyst Projections for Key Metrics Reveal About Teladoc (TDOC) Q4 Earnings (Zacks) -9.30%
07:19AM	Why Teladoc Health, Inc. (TDOC) Crashed on Thursday (Insider Monkey)
Feb-20-25 12:05PM	Blue Orca short Teladoc, says far less profitable than believed (TipRanks) -7.84%
Feb-19-25 03:54PM	Why Teladoc Health (TDOC) Crashed on Tuesday? (Insider Monkey) +5.03%
02:46PM	Teladoc Health, Inc. (TDOC): the Best Performing Healthcare Stock So Far in 2025 (Insider Monkey)
Feb-15-25 10:00AM	Is Teladoc Stock a Buy? (Motley Fool)
Feb-14-25 01:16PM	Teladoc Health, Inc. (TDOC): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey) +6.07%

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rodrigues Fernando M.	President of BetterHelp	Jun 03 '25	Sale	6.91	4,174	28,842	0	Jun 03 05:37 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 02 '25	Sale	6.86	2,358	16,176	4,174	Jun 03 05:37 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 02 '25	Sale	6.86	5,808	39,843	69,773	Jun 03 05:37 PM
Bliss Kelly	President, U.S. Group Health	Jun 02 '25	Sale	6.86	4,653	31,920	50,266	Jun 03 05:36 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Jun 02 '25	Sale	6.86	13,856	95,052	132,443	Jun 03 05:36 PM
Nueno Carlos	President, International	Jun 02 '25	Sale	6.86	3,958	27,152	17,645	Jun 03 05:36 PM
Rodrigues Fernando M.	Officer	Jun 03 '25	Proposed Sale	6.91	4,174	28,842		Jun 03 10:53 AM
Murthy Mala	Officer	Jun 02 '25	Proposed Sale	6.86	13,856	95,052		Jun 02 03:46 PM
Rodrigues Fernando M.	Officer	Jun 02 '25	Proposed Sale	6.86	2,358	16,176		Jun 02 03:45 PM
Vandervoort Adam C	Officer	Jun 02 '25	Proposed Sale	6.86	5,808	39,843		Jun 02 03:44 PM
Bliss Kelly	Officer	Jun 02 '25	Proposed Sale	6.86	4,653	31,920		Jun 02 03:43 PM
Nueno Carlos	Officer	Jun 02 '25	Proposed Sale	6.86	3,958	27,152		Jun 02 03:38 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Apr 07 '25	Sale	6.81	7,494	51,012	121,467	Apr 08 04:23 PM
Murthy Mala	Officer	Apr 07 '25	Proposed Sale	6.81	7,494	51,012		Apr 07 05:15 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 20 '25	Sale	8.42	20,586	173,416	116,309	Mar 21 04:20 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 20 '25	Sale	8.42	11,011	92,757	64,308	Mar 21 04:20 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 21 '25	Sale	8.00	2,663	21,304	0	Mar 21 04:19 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 20 '25	Sale	8.42	1,503	12,661	2,663	Mar 21 04:19 PM
Bliss Kelly	President, U.S. Group Health	Mar 20 '25	Sale	8.42	9,470	79,775	45,384	Mar 21 04:19 PM
Nueno Carlos	President, International	Mar 20 '25	Sale	8.42	8,266	69,633	12,891	Mar 21 04:19 PM
Rodrigues Fernando M.	Officer	Mar 21 '25	Proposed Sale	8.00	2,663	21,304		Mar 21 10:16 AM
Rodrigues Fernando M.	Officer	Mar 20 '25	Proposed Sale	8.42	1,503	12,661		Mar 20 03:25 PM
Bliss Kelly	Officer	Mar 20 '25	Proposed Sale	8.42	9,470	79,773		Mar 20 03:13 PM
Murthy Mala	Officer	Mar 20 '25	Proposed Sale	8.42	20,586	173,412		Mar 20 03:12 PM
Vandervoort Adam C	Officer	Mar 20 '25	Proposed Sale	8.42	11,011	92,754		Mar 20 03:10 PM
Nueno Carlos	Officer	Mar 20 '25	Proposed Sale	8.42	8,266	69,631		Mar 20 03:09 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 05 '25	Sale	9.20	3,558	32,734	0	Mar 06 04:04 PM
Rodrigues Fernando M.	Officer	Mar 05 '25	Proposed Sale	9.20	3,558	32,734		Mar 05 09:44 AM
Rodrigues Fernando M.	President of BetterHelp	Mar 03 '25	Sale	9.68	1,933	18,719	3,558	Mar 04 04:07 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	9.68	8,630	83,573	99,962	Mar 04 04:07 PM
Nueno Carlos	President, International	Mar 03 '25	Sale	9.68	2,347	22,728	2,932	Mar 04 04:06 PM
Bliss Kelly	President, U.S. Group Health	Mar 03 '25	Sale	9.68	2,904	28,122	35,421	Mar 04 04:06 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 03 '25	Sale	9.68	3,935	38,107	53,919	Mar 04 04:06 PM
Bliss Kelly	Officer	Mar 03 '25	Proposed Sale	9.68	2,904	28,124		Mar 03 04:29 PM
Murthy Mala	Officer	Mar 03 '25	Proposed Sale	9.68	8,630	83,576		Mar 03 04:22 PM
Nueno Carlos	Officer	Mar 03 '25	Proposed Sale	9.68	2,347	22,729		Mar 03 04:21 PM
Rodrigues Fernando M.	Officer	Mar 03 '25	Proposed Sale	9.68	1,933	18,720		Mar 03 04:20 PM
Vandervoort Adam C	Officer	Mar 03 '25	Proposed Sale	9.68	3,935	38,108		Mar 03 04:17 PM
Nanis Nikolaos P.	Officer	Jan 03 '25	Proposed Sale	9.33	502	4,681		Jan 03 05:31 PM
Waters Michael Willem	Officer	Dec 16 '24	Proposed Sale	10.28	4,652	47,823		Dec 16 10:46 AM
Nueno Carlos	President, International	Dec 03 '24	Sale	11.23	2,890	32,455	0	Dec 03 05:30 PM
Nueno Carlos	President, International	Dec 02 '24	Sale	11.93	2,389	28,494	2,890	Dec 03 05:30 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '24	Sale	11.93	4,004	47,756	50,050	Dec 03 05:29 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Dec 02 '24	Sale	11.93	8,783	104,755	92,788	Dec 03 05:28 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '24	Sale	11.07	14,091	156,001	0	Dec 03 05:26 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '24	Sale	11.93	7,873	93,901	14,091	Dec 03 05:26 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '24	Sale	11.93	2,040	24,331	32,244	Dec 03 05:20 PM
Rodrigues Fernando M.	Officer	Dec 03 '24	Proposed Sale	11.07	14,091	156,002		Dec 03 12:11 PM
Nueno Carlos	Officer	Dec 03 '24	Proposed Sale	11.23	2,890	32,455		Dec 03 11:02 AM
Raman-Tangella Vidya	Officer	Dec 03 '24	Proposed Sale	11.23	468	5,256		Dec 03 09:56 AM
Murthy Mala	Officer	Dec 02 '24	Proposed Sale	11.93	8,783	104,752		Dec 02 04:53 PM
Raman-Tangella Vidya	Officer	Dec 02 '24	Proposed Sale	11.93	1,588	18,940		Dec 02 04:49 PM
Vandervoort Adam C	Officer	Dec 02 '24	Proposed Sale	11.93	4,004	47,754		Dec 02 04:45 PM
Waters Michael Willem	Officer	Dec 02 '24	Proposed Sale	11.93	4,234	50,498		Dec 02 04:41 PM
Nanis Nikolaos P.	Officer	Dec 02 '24	Proposed Sale	11.93	4,218	50,307		Dec 02 04:11 PM
Bliss Kelly	Officer	Dec 02 '24	Proposed Sale	11.93	2,040	24,330		Dec 02 04:08 PM
Nueno Carlos	Officer	Dec 02 '24	Proposed Sale	11.93	2,389	28,493		Dec 02 04:04 PM
Rodrigues Fernando M.	Officer	Dec 02 '24	Proposed Sale	11.93	7,873	93,899		Dec 02 03:25 PM
Verstraete Stephany	Former Officer	Nov 19 '24	Proposed Sale	8.92	75,463	673,130		Nov 19 11:25 AM
Geshuri Arnnon	Former Officer	Nov 15 '24	Proposed Sale	9.21	34,456	317,512		Nov 15 03:32 PM
Geshuri Arnnon	Former Officer	Nov 12 '24	Proposed Sale	9.58	60,000	574,800		Nov 12 02:20 PM
Raman-Tangella Vidya	Officer	Nov 05 '24	Proposed Sale	8.88	1,537	13,649		Nov 05 10:08 AM
Waters Michael Willem	Officer	Nov 04 '24	Proposed Sale	8.67	6,097	52,845		Nov 04 04:50 PM
Geshuri Arnnon	Former Officer	Nov 04 '24	Proposed Sale	8.87	160,278	1,421,691		Nov 04 04:21 PM
Raman-Tangella Vidya	Officer	Nov 04 '24	Proposed Sale	8.67	4,776	41,395		Nov 04 03:55 PM
Verstraete Stephany	Former Officer	Oct 31 '24	Proposed Sale	9.23	16,992	156,755		Oct 31 03:13 PM
Trencher Daniel	Former Officer	Oct 29 '24	Proposed Sale	9.15	18,000	164,739		Oct 29 01:17 PM
Turitz Andrew	Former Officer	Oct 11 '24	Proposed Sale	9.49	38,983	370,102		Oct 11 03:27 PM
Kornwasser Laizer	Former Officer	Oct 09 '24	Proposed Sale	8.90	29,516	262,825		Oct 09 03:16 PM
Trencher Daniel	Former Officer	Oct 08 '24	Proposed Sale	8.58	8,343	71,612		Oct 08 03:22 PM
Turitz Andrew	Former Officer	Oct 08 '24	Proposed Sale	8.58	7,398	63,501		Oct 08 03:21 PM
Bliss Kelly	President, U.S. Group Health	Oct 02 '24	Sale	8.68	897	7,783	28,203	Oct 02 04:13 PM
Nanis Nikolaos P.	Officer	Oct 02 '24	Proposed Sale	8.68	454	3,939		Oct 02 03:20 PM
Bliss Kelly	Officer	Oct 02 '24	Proposed Sale	8.68	897	7,783		Oct 02 03:19 PM
Raman-Tangella Vidya	Officer	Oct 02 '24	Proposed Sale	8.73	14,737	128,654		Oct 02 10:22 AM
Trencher Daniel	Former Officer	Sep 16 '24	Proposed Sale	8.21	9,960	81,773		Sep 16 03:35 PM
MCKINLEY THOMAS	Director	Sep 12 '24	Buy	7.69	4,000	30,756	39,077	Sep 13 05:14 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 04 '24	Sale	7.26	20,773	150,812	20,773	Sep 05 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 04 '24	Sale	7.26	468	3,398	33,665	Sep 05 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Sep 03 '24	Sale	7.16	1,795	12,859	44,914	Sep 04 04:13 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 03 '24	Sale	7.16	8,750	62,685	85,767	Sep 04 04:13 PM
Nanis Nikolaos P.	Chief Technology Officer	Sep 03 '24	Sale	7.16	1,033	7,400	75,410	Sep 04 04:12 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 03 '24	Sale	7.16	2,817	20,181	46,250	Sep 04 04:12 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Sep 03 '24	Sale	7.16	2,083	14,923	48,843	Sep 04 04:12 PM
Cave James L.	INTERIM CAO	Sep 03 '24	Sale	7.16	555	3,976	13,808	Sep 04 04:12 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Sep 03 '24	Sale	7.16	1,777	12,730	31,465	Sep 04 04:12 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Sep 03 '24	Sale	7.16	4,218	30,218	78,309	Sep 04 04:11 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 03 '24	Sale	7.16	1,617	11,584	41,546	Sep 04 04:11 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 03 '24	Sale	7.16	1,114	7,981	34,133	Sep 04 04:11 PM
Raman-Tangella Vidya	Officer	Sep 04 '24	Proposed Sale	7.26	468	3,398		Sep 04 10:25 AM
Turitz Andrew	Officer	Sep 04 '24	Proposed Sale	7.26	20,773	150,812		Sep 04 10:18 AM
Geshuri Arnnon	Officer	Sep 03 '24	Proposed Sale	7.16	1,795	12,859		Sep 03 04:06 PM
Nanis Nikolaos P.	Officer	Sep 03 '24	Proposed Sale	7.16	1,033	7,400		Sep 03 03:54 PM
Murthy Mala	Officer	Sep 03 '24	Proposed Sale	7.16	8,750	62,681		Sep 03 03:49 PM
Verstraete Stephany	Officer	Sep 03 '24	Proposed Sale	7.16	2,083	14,922		Sep 03 03:41 PM
Waters Michael Willem	Officer	Sep 03 '24	Proposed Sale	7.16	4,218	30,216		Sep 03 03:35 PM
Vandervoort Adam C	Officer	Sep 03 '24	Proposed Sale	7.16	2,817	20,180		Sep 03 03:32 PM
Raman-Tangella Vidya	Officer	Sep 03 '24	Proposed Sale	7.16	1,114	7,980		Sep 03 03:27 PM
Trencher Daniel	Officer	Sep 03 '24	Proposed Sale	7.16	1,777	12,730		Sep 03 03:13 PM
Turitz Andrew	Officer	Sep 03 '24	Proposed Sale	7.17	1,617	11,587		Sep 03 03:09 PM

LFMD

LifeMD Inc

HIMS

Hims & Hers Health Inc

AIRS

Airsculpt Technologies Inc

TOI

Oncology Institute Inc

TDOC

Teladoc Health Inc

Upgrade your FINVIZ experience